Monopar Therapeutics (1IY0.F) Q3 2024 Earnings

9AugConfirmed
Q3 2024
-0.46
-0.12
0.21
0.54

Details

Expected EPS
-0.458025
Actual EPS
-0.458025
Surprise EPS
0
Surprise Percent
+0%

Description

Monopar Therapeutics (1IY0.F) has reported earnings of -0.458025 per share for Q3 2024.

0 Comments

Share your thoughts